A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

Study Identifier
192024-095
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Protocol
Available Language(s): English
Statistical Analysis Plan
Available Language(s): English
Scientific Result Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English, Danish, French, Polish, Russian

Study Details

Medical Condition
  • Glaucoma - Other
  • Ocular Hypertension
  • Study Drug
  • Bimatoprost SR
  • Sham Bimatoprost SR
  • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    This study will evaluate the intraocular pressure (IOP)-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty in participants with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy (e.g., due to intolerance or nonadherence).

    Study Locations

    Location
    Status
    Location
    Eye Center South
    Dothan, Alabama, United States, 36301
    Status
    Not applicable
    Location
    Arizona Eye Center
    Chandler, Arizona, United States, 85224
    Status
    Not applicable
    Location
    Walman Eye Center
    Chandler, Arizona, United States, 85225
    Status
    Not applicable
    Location
    Shasta Eye Medical Group, Inc.
    Redding, California, United States, 96002
    Status
    Not applicable
    Location
    Wolstan & Goldberg Eye Associates
    Torrance, California, United States, 90505
    Status
    Not applicable
    Location
    Eye Associates of Colorado Springs
    Colorado Springs, Colorado, United States, 80909
    Status
    Not applicable
    Showing {first} - {last} of {total} Results